Not All Immune Checkpoints Are Created Equal

Antibodies that block T cell inhibition via the immune checkpoints CTLA-4 and PD-1 have revolutionized cancer therapy during the last 15 years. T cells express additional inhibitory surface receptors that are considered to have potential as targets in cancer immunotherapy. Antibodies against LAG-3 a...

Descripción completa

Detalles Bibliográficos
Autores principales: De Sousa Linhares, Annika, Leitner, Judith, Grabmeier-Pfistershammer, Katharina, Steinberger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127213/
https://www.ncbi.nlm.nih.gov/pubmed/30233564
http://dx.doi.org/10.3389/fimmu.2018.01909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127213/
https://www.ncbi.nlm.nih.gov/pubmed/30233564
http://dx.doi.org/10.3389/fimmu.2018.01909

Ejemplares similares